"Algeria Pharmaceuticals & Healthcare Report Q4 2013" Is Now Available at Fast Market Research
Although the Pharmaceutical Research and Manufacturers of America (PhRMA) is encouraged by the Algerian government's intention to improve its pharmaceutical policies, it is evident that the Ministry of Health continues to make the entire process of launching patented medicines, from registration to importation, difficult for innovative drugmakers. While these policies are clearly detrimental to innovative drugmakers, import restrictions and volume control policies are also having a negative effect on local medicines supply and therefore patients' health. As medicines supply is...
View full press release